Quote | Medexus Pharmaceuticals Inc (OTCMKTS:MEDXF)
Last: | $1.35 |
---|---|
Change Percent: | 0.0% |
Open: | $1.3 |
Close: | $1.35 |
High: | $1.38 |
Low: | $1.2815 |
Volume: | 25,692 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Medexus Pharmaceuticals Inc (OTCMKTS:MEDXF)
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...
Message Board Posts | Medexus Pharmaceuticals Inc (OTCMKTS:MEDXF)
Subject | By | Source | When |
---|---|---|---|
Any thoughts on the quarter? | rado | investorshub | 08/17/2021 8:55:33 PM |
Wow! A post?? Yeah, amazing potential. Going much higher | ronpopeil | investorshub | 06/12/2021 12:11:50 AM |
Let's gooooo $MEDXF | Phils Goodman | investorshub | 06/11/2021 11:47:30 PM |
I like this one a lot. Strong revenues. | ronpopeil | investorshub | 04/22/2021 8:29:43 PM |
started a new position last week and up | arnoldisking | investorshub | 03/16/2021 9:40:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc Company Name:
MEDXF Stock Symbol:
OTCMKTS Market:
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...
Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 million Management to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 7, 2024) - Medexus Pharm...